CA1167747A - Stabilized enzymic solutions for determining urea - Google Patents

Stabilized enzymic solutions for determining urea

Info

Publication number
CA1167747A
CA1167747A CA000366092A CA366092A CA1167747A CA 1167747 A CA1167747 A CA 1167747A CA 000366092 A CA000366092 A CA 000366092A CA 366092 A CA366092 A CA 366092A CA 1167747 A CA1167747 A CA 1167747A
Authority
CA
Canada
Prior art keywords
solution
urease
stabilized
amount
recited
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000366092A
Other languages
French (fr)
Inventor
Ivan E. Modrovich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA000366092A priority Critical patent/CA1167747A/en
Application granted granted Critical
Publication of CA1167747A publication Critical patent/CA1167747A/en
Expired legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Abstract of the Disclosure A stabilized urease solution is disclosed comprising water, buffering agents, a bacteriostat, chelating agent, polyhydroxy organic compound and urease. The preferred buffering agents are selected from low conductivity Zwitterionic buffer salts, such as N-2-hydroxymethyl-piperazine-N'-2-ethanesulfonic acid, triethanolamine, tris(hydroxymethyl)aminomethane, diethanolamine, amino-methyl propanol and mixtures thereof.

Description

7~r7 12823/~A~7/nk STABILIZED E~ZY~iIC SOLUTIO~IS FOR DETERMINING UREA

Background of the ~nvention The present invention relates to stabilized enzymic solutions for determining urea. Such stabilized solutions have utility in determining the quantitative amount of urea in human sera, such as blood, plasma and the like.
More particularly, the invention relates to stabilized en7ymic solutions for use in methods for determining urea based upon conductivity measurements.
A method for determining urea was reported by w. T.
Chin and ~r, I'roontje, "Conductivity ~ethod for Determina-tion of Urea," Anal. Chem, 33:1757-1760 (1961). The _ .
method o~ Chin and Kroontje was based upon the difference in electrical conductivity of urea and ammonium carbonate produced by the reaction of urease with urea in solution.
The method of Chin and ~roontje was modi~ied by P. Bourrelly and V. Bourrelly-Durand, J.Chim. Phys., 62:673-677 (1965) and by ~ anss and A. Rey, Biochim. Biophys. Acta., 227:~30-638 (1971).
An improvement in the method of measuring urea quantitatively using conductivity measurements was developed by G. Paulson, R. Roy and J. Sternberg, "A
Rate-Sensing Approach to Urea Measurement," Clin. Chem., ; 17:G44 (1971). The improved method was based on 77~L7 l conductivimetric ra-te-sensing. The method employed the rate of increase of conductivity of a solution as urease catalyzes the hydrolysis of urea to ammonium carbonate by the reaction:

(l) ~1 W~ ~N~ o Urease~ (MH4)2C03 -~ NM4 + HC03 The observed rate of chanye of conductivity was shown to be proportional to the urea concentration in the sample.
In particular, the rate of change during the interval from ten to twenty seconds following addition of the sample to a buffered urease solution at a pH 7 and temperature of 34C was determined to be proportional to the urea concen tration. The rate-sensing method is sufficiently precise and accurate and has found routine use in clinical chemistry laboratories.
Other methods for quantitative measuring of urea are based on colorimetric and spectrophotometric analyses.
For example, in the reaction sequence:

C
(2) ~12~ ~ \ NH2 + I120 - -> 2NH3 + C02 the pro~uction of ammonia or C02 can be quantitatively measured photometrically. The reaction sequence (2) above is the same as reaction sequence (l) except that (2) is written as if it were a nonaqueous system to sho~
that ammonia and carbon dioxide are products o~ urease activity in urea. The ammonia produced can be measured photometrically by the reaction:
(3) ~1113 + L1-aminoantipyrinc + NaOCl ~ blue color . . .

i'7~

12~23 3 1 The intensity of the blue color produced can be correlated to the amount of ammonia. The ammonia can also be measured through the following reaction sequence:
(4) NH3 ~ etoglutrate -~ N~DH - _ I
glutarate dehydrogenase glutamate -~ H~O -~ NAD ~ --In this reaction sequence the ~ADH acts as a reducing lo agent. The NADTI has an absorbance at 340mm and the N~Ddoes not. Thus, the absorbance at 340mm can be correlated to the amount of ~I3 present in a sample.
Stability of enzymic solutions used in diagnostic assays is important in providing methods of analysis ~hich exhibit precision and uniformity among separate determinations when conducted over a period of elapsed time. Instability of enzymic solutions, in addition to not providing reproducibility of assays, can also add to the ever increasing cost of medical services because the unstable enæymic solutions need to be discarded and fresh solutions formulated.
It has recently been estimated that about 25 percent of all in vitro diagnostic tests conducted annually in the United States, are unreliable~ Unreliable tests can result in unnecessary medical treatment, the with-holding of necessary treatment and lost income. Becauseof their high specificity, the use o enzyme determinations has significantly increased during the last few years and indications are that this trend will continue. However, riqorous quality control measures are required to assure the accuracy and consistency o results. This require-ment derives from the fact that the e~act nature of enzymes, as ~Jell as mechanisms of their reactions, remains unknown for the most part.
3~

'7~

1'3 3 4 1 At present, the greatest limitation in the diagnostic reagent manufacture, by far, lies in the uns-table charac~
teristics o~ the enzymic solutions. Current urea enzyrnic diagnostic methodologies require the use of labile ingredients. Due to the labile nature of the enzymes, rlgorous quality control is required over the production of such enzymic solutions, in the reconstituting dry media ~reparations and formulation of such enzytnic solu-tions. ~uch quality control is costly. ~qoreover, if lo such control in any step in the process is not maintainedwithin a high degree of control standards, the quality of the final product can be reduced materially leading to decreased precision in assay results.
The present commercial state-of-the~art used for stabilizing the reactive ability of enzymes or coenzymes is b~r locking them into a solid matrix, either by freeze drying, dry blending such as used for tableting dry powders primarily in the pharmaceutical diagnostic and related industries, and immobilization by locking the chemical structure of the enzyme into a solid matrix.
Contrary to the sophistication these terms imply, these approaches are neither practical nor desirable and are also eApensive. The manufacturer is forced to remove the water and supply a partial product, thus relinquishing ~5 part of the ~uality control cycle in the dilution and use of the final product. Laboratories are forced to pay the high cost of packaging, reagent waste, free~e drying and dry blending. ~sefulness of the product is furtller lirlited by packaging modes and sizes.
~ Furthermore, good product uniformity is difficult to achieve, especially in the laboratories where the products are ~o be u~ilized in diagnostic assay. -This condltion is eAemplifie~l by tlle fact that most commercial freeze-dried :;5 ~.
.

qil 4 ` ~1~ A 1' controlled sera (reference serum) lists the acceptable bottle-to-bottle variation of enzyme constituents at ~ 10 percent of the mean. Generally, the reconstituted freeze-dried urease solutions have a stability of about 24 hours to 5 days at room temperature conditions. Their use is then limi-ted by such short shelf-life.
The present invention i5 uniquely designed so that the enzyme solution, although containing labile ingredients in a li~uid reagent, are effectively "stabilized" thereby controlling lQ the activity of the labile ingredients in the liquid solution.
The means of stability insures long-term stability in a liquid media. Moreover, close tolerance contol can be achieved in the manufacturing of a high quality product which eliminates the inconvenience of the rigid package size, the high cost of packaging and freeze drying, and reagent waste.
SUMMARY OF THE INVE.NTION
In accordance with the present invention there is provided a stabilizing urease solution comprising water, an amount of a buffering agent which is at least one zwitterionic, 2Q low-conductivity buffering agent present to provide a pH in the range of from about 5 to about 9, a bacteriostat, a polyhydroxy organic compound, and urease.

'7 ~ Sa Also in accordance with the .invention there is provided '' a stabilized urease solution compr.ising:
essentially heavy-metal-free water;
N-2-hydroxyethyl-piperazine-N'-2-ethanesulfonic acid in an amount from about 0.5 to about 5 percent by weight of the water;
a zwitterionic, low-conductivity buffering agent in an amount suff'icient to provide a pH within the range of about 5 to 9 and selected from the group consisting of N-2-hydroxyethyl-piperazine-N'-2-ethanesulfonic acid, triethanolamine, tris~hydroxymethyl)aminomethane, diethanolamine, aminomethyl propanol and mixtures thereof;
a bacteriostat in an amount sufficient to prohibit bacterial growth, selected from 2,4-dichlorophenol and alcohols
5 that are nondegradative to urease;
a chelating agent in an amount sufficient to chelate with any heavy metals present, selected from ethylenediaminetetraacetic acid and amino acids;
a polyhydroxy organic compound in an amount of about 50 percent by volume of the solution and selected from the group consisting of glycerol, ethylene glycol, sorbitol and propylene glycol; and urease in an amount greater than about 25,000 I~/l +
25~.

- 5b Furthe~ in accordarlce with the invention there is provided a kit comprising a stabilized concentrated urease solution comprising;
water, n-2-hydroxymethyl-piperazine-N'-2-ethanesulfonic acid, 2,4-dichlorophenol, ethylenediaminetetraacetic acid, trithanolamine and a polyhydroxy organic compound selected from the group consisting of glycerol, ethylene glycol, sorbitol and propylene glycol, and urease enzyme in an amount greater than 25,000 IU/l + 25%.
Further in accordance with the invention there is provided a kit comprising a stabilized concentratged urease solution comprising essentially heavy-metal-free water;
N-2-hydroxyethly-piperazine-N'-2-ethanesulfonic acid in an amount from about 0.5 to about 5 percent by weight of the water, 2,4-dichlorophenol in an amount from a~out 0.1 to about 1.0 percent by weight, ethylene-diaminetetraacetic acid in an amount sufficient to chelate with any heavy metals present in the solution;
2Q triethanolamine in an amount sufficient to provide a pH
within the range of about 5 to 9, and a polyhydroxy organic compound in an amount of about 50 percent by volume of the solution and selected from the group consisting of glycerol, ethylene glycol, sorbitol and propylene glycol; and urease enzyme in an amount greater than 25,000 IU/l +

~5~.

7~
- 5c Thus, labile enzymes, useful in the diagnostic assay oi-urea are treated according to the invention resulting in long term stability without deleteriously affecting enzyme activity, conductimetric properties, or photometric absorptivity. The invention provicles reagents wherein quality control is assured throughout manuiacturing, packaging, storage, and the use. The inconvenience of rigid package size is eliminated as is the high cost of packaging, freeze drying, and reagent waste. The liquid enzyme system for urea assay, as described herein, provides desired fle~ibility to urea assay determination. The stabilized liquid enzyme solutions of the invention can be compared with fresh formulated reagents prepared from freeze-dried enzymes. Such studies show a one-to one correlation between aged liquid and fresh reagents with comparable 1~823 6 1 sensitivi-ty and preclsion. The liquid system of the present invention offers better reagent homoyeneity and pac~ac31ng, as well as flexibili-ty and usage, in contrast to the freeze-dried or dry media preparati.ons.
In dia~nostic urea assay, t:he stabilization of the la~ile components and particularly the labile urease in a ready-to-use liquid media, is a new and exciting approach to satisfy the needs of the clinical laboratory and the reliabili-ty demands of the regulatory authorities. The fle~ibility of these liquid systems insures their appli-cability to automated ins-trumentation, as well as their convenience in manual testings.
Stabilization of the urease useful in the deter-mination of urea is accomplished, in accordance with ~ 4S~c~ ~P
the invention, by mixing tris(hydroxymethyl)aminomethanewith water, which water has been treated for removal of metals and especially heavy metal ions, e.g., triple distilled water can be used. To the mixture is added N-2-hydroxymethyl~piperazine-N -2-athanesulfonic acid and ethylenediaminetetraacetic acid (as its disodium salt). To the mix-ture is added a polyhydroxy organic compound,such as glycerol, ethylene glycol, sorbitol and propylene glycol. The pH of the mixture is adjusted to about 6-~, such that the ammonia produced by the 2~ urease activity will not affect the pH. The urease is then added to the mixture.
The preferred stabilized urease solution for use in urea determination is compounded in the following manner. N-2-hydroxymethyl-piperaæine-N -2-ethanesulfonic acid is added and mixed in distilled water. To the mi~ture is added 2,4-dichlorophenol and the disodium salt of ethylenediaminetetraacetic acid. Triethanol amine is t11en added and the pH adjusted to the range of pH ~-8.

..
~.~

7~7 A polyhydroxy organic compound such as glycerol, ethylene glycol, sorbitol and propylene glycol is added, and preferably glycerol is added. The aqueous solution of enzyme urease is then added.
The resultant solution can be used in the determination of urea.
In use, the solution is diluted with water to obtain the desired amount of urease activity.
In an alternative embodiment herein of the stabilized urease solutions there can be prepared three solutions:
(1) an initial solution hereafter called primary solution;
(2) a reagent concentrate solution prepared from the primary solution; ànd (3) a diluent solution. The primary solution comprises distilled water, trie-thanolamine, ethylenediamine-tetraacetic acid (free acid), N-2-hydroxymethyl-piperazine-N'-2-ethanesulfonic acid and 2,4-dichlorophenol. The reagent concent-rate solution comprises the primary solution, a polyhydroxy organiccompound such as glycerol, ethylene glycol, sorbitol and propylene glycol, and urease. The diluent solution can comprise distilled water or a solution of 2,4-dichlorophenol in distilled water, such as up to about one percent by weight 2,4-dichlorophenol and preferably 0.004 percent by weight.
The solutions herein have extended shelf life generally in useable form (diluted) of about one month at room temperature.
Longer life is found at lower temperatures.
These and many other features and attendant advantages of the invention will become apparent as the invention kecomes better understood by reference to the following detail description.

:
' ~. ~

:

77~7 1 Detailecl Descrip-tion of the Invention ~ rhe stabilized enzyme solutions herein can be used i.n thc cl:inical field ~or the dctermination o~ urea. The stabilized enzyme ~olutions herein can be used in conduc-tivimetric methods of analyses or photometric analyscs.Tlle stabili~.ed urease solutions have utility in assays based upon the following reaction seciuence:

C
(5) ~12~1~ ~ N~12 ~ ~2 - > (NH~)2C03 ~ NH~ + IIC03 hether the eonductivity, rate of ehange of conduetivity or eoncentration of pr.oducts ~ammonia or carbon dioxide) are determined. The stabilized urease solutions herein ~ have utility in the enzymic breakdown of urea to produets .`~ which can ~e measured and such measurements correlated . to urea concentration. In particular, the stabilized urease solutions have applicability in urea determinations based upon rate o~ change of conductivityO When the stabilized enzyme solutions herein are to be used in urea detcr~inations based on photometric methods, a dye or . compound absorbing light at a particular wavelengtll can . be added to the soluti.ons herein. For measuring urea concentration by rate of change o.f conductivity, the stabilized urease enzylne solutions herein can be used as described.
In thc ~referred utility of the stabilized urease .` solutions herein, the stabilized urease solutlons can be used in coi!lbination ~.~ith electronic analyzers which measure the conductivity, rate of change of the conductivity and correlate thc measurcd cuantities to the concentration of ; urea in the sample. Such instruments are commercial].y .

7~7 g avallable and the solutions herein have especial applicability in such commercially available instruments. A particularly preferred commerically available instrument is the BUN Analyzer 2, or the "ASTRA" (T.M. ) both available from Beckman Ins-truments, Inc.
Both the "ASTRA" (T.M.) and the BUN Analyzer 2 utilize the enzymatic conductivimetric rate method employing a conductivity electrode immersed in the sample and an electronics system tha-t measures the rate of increase :in conductivity when a precise volume of sample is pipetted into a reac-tion cup containing the stabilized urease solution. When a sample is injected into the reaction cup containing the urease enzyme solution, the urea i.n the sample undergoes the reaction designated in reaction sequence (5) above.
The reaction converts the nonionic urea to an ionic form, ammonium carbonate. During the reaction, the rate of increase of solution conductivity is directly proportional to the concent.ration of urea, then present in the reaction cup. The maximum observed rate measured thirteen seconds after i.njection of the sample has been . shown to be a direct measure of the concentration of urea orig-inally present in the sample at the time of introduction into the reaction cup. The instrument measures and holds this rate and : provides a digital readout (calibrated using a standard having a known urea concentration) corresponding to the urea concentration in the sample.
The stabilized enzyme solutions herein can be prepared in a ready-to-use solution form that need only to be combined with the sample to be tested for urea content. The stabilized enzyme solutions herein can also be prepared in a concentrate form which can be diluted with a provided diluent solution or in a concentrate form which can be diluted with water by the user prlor to .
.. .

7~
- lo -performing a urea determination. When the stabilized enzyme solution is provided as a concentrate, it can be provided in a kit form to the end user (i.e., clinical laboratory), which kit can contain the concentrate solution and diluent solution.
The stabilized urease enzyme solution is prepared by mixing N-2-hydroxymethyl-piperazine-M'-2~ethanesulfonic acid (hereinafter referred to as HEPES) with water which has been conditioned, such as by distillation or deionization to remove metals and especially heavy metals. The water used is essentiall~ free of such metal ions as the presence of metal ions can poison the urease enzyme. The HEPE~ is used in an amount that is about 0.5 to about 5 percent by weight of the water used. Amounts less than 0.5 percent by weight can be used and amounts greater than 5 percent by weight can be usea, but for optimum shelf life such amounts offer no apprec-iable advantage. HEPES is commercially available as 4-(2~
hydroxyethyl)-l-piperazine-ethanesulonic acid (F.W. 238.31) Erom J. T. Baker Chemical Company. For the purposes herein this commercially available product can be used.
To the mixture is added a bacteriostat for enhancing the shelf life of the solution to be prepared. The bacteriostat inhibits the growth of bacteria which can be deleterious to the urease enzyme. The preferred bacteriostats inhibit bacteria growth without denaturing the urease. Alcohols can be used as the bacteriostat. The preferred bacteriostat is, 2,4-dichlorophenol. The use of phenol is undesirable as it can denature the urease. The bacteriostat is added in an amount sufficient to prohibit bacterial growth. For 2,4-dichlorophenol the amount is from about 0.1 to about 1.0 percentby weight of the final solution. Lesser amounts can be ,~

: ~i 7~

used but do not offer the bacterial inhibition that is offered by 0.1 percent by weight. Amounts greater than 1.0 percent by weight can be used but offer no appreciable advantage over amounts up to 1.0 percent by weight.
To the resultant mixtura is added ethylenediamine-tetraacetic acid (hereinafter referred to as EDTA). The EDTA can be added as the free acid or as a salt of the acid such as the disodium salt. Th~ese forms of EDTA are commercially available and for the purposes herein the commercially available products are suitable. The EDTA is added as a chelating agent for complexing any remaining metal ions and especially heavy metal ions that can be in the solution or the sample when added. Other chelating agents can be used such as various amino acids. However, in the conductivity measuring method of urea analysis, such other chelating agents should be tested to determine their influence on conductivity and to see if they have the proper conductivity for the system. The chelating agent is added in an amount sufficient to chelate with the metal ions present, which amount is generally up to about one percent by weight.
Triethanolamine is then added to the mixture.
; Tris(hydroxymethyl)aminomethane can also be used as a buffering compoun~ but triethanol amine is pr~ferred as it is less ionic and does not effect the conductivity to any substantial amount. The triethanolamine and HEPES are added to form a solution providing a pH within the range of 5-9 and preferably
6-8. The solution should contain the HEPES and triethanolamine in sufficient amounts such that the produced ammonia by the reaction of urease or urea does not effectively change the pH of the media~ The pH is preferably on the low side of 7 i to permit optimum enzyme activity. At a pH greater than 9 and even greater than 8, some ammonia produced by the reaction of urease and urea can be freely liberated from the solution.
A polyhydroxy organic compound is then added to the mixture for aiding the stabilization o~ the urease enzyme.
Preferred polyhydroxy organic compounds can be selected from the group consisting of glycerol, ethylene glycol, sorbitol, and propylene glycol. The preferred polyhydroxy compound is glycerol. Generally, the polyhydroxy compound is used in an amount of about 50 percent by volume of the solution.
- The urease enzyme is then added to the solution.
The urease enzyme comes from the Jack Bean and i9 commercially available in a freeze-dried form, concentrated salt or glycerol suspension. All of these forms can be used, however, if conductivimetric analyses are to be used, the salt form is undesirable as it can affect conductivity. The urease is added in a amount which provides about 25,000 IU/l ~ 25 percent in the working solution, that is, the solution that is combined with the sample to be tested. Appropriately, the amount of urease added to a stabilizing solution depends on whether the solution is to be a working ~olution or a concentrate solution. The activity of the urease is in terms of the GLDH method wherein one IU of enzyme activity in an ADP activated assay system determined at 37C and pH 7.5 is that amount of urease that consumes lmM of urea per minute under the assay conditions. As a general rule of thumb, 1 unit per Nessler analysis is equivalent to 3 units by the GLDH method.
The stabilized urease solution, when formed as a concentrate, has a projected shelf life of greater than ;77~

two years at 4C. The combined, or diluted, stabilized urease solution has a stability of four to six weeks at room temperature which correlat:es to about six months at 4C.
The stabilized urease solution can be provided in a concentrate form by combining water, triethanolamine, E~TA, HEPES, 2,4-dichlorophenol, glyc:erol and urease in a relatively high amount such that the concentrate solution can be approp-riately diluted to provide the desired 25,000 IU/l i 25 percent. A diluent can be water (essentially metal and heavy metal free) which can be added by the user or can be a provided diluent. The provided diluent can be a 0.004 percent by weight aqueous solution of 2,4-dichlorophenol.
This diluent and enzyme concentrate can be provided in kit form to the clinical laboratory for dilution prior to using.
The stabilized urease solutions are further illustrated by, but not intended to be limited to, the following examples.

Example 1 A stabilized urease solution for use in the rate of change of conductivity method of urea analysis was pre-pared by mixing 2.07 grams (g) HEPES in 240 ml distilled water. To the mixture was added 2.5 g 2,4-dichlorophenol and 1.4 g diso~ium salt of EDTA. The mixture was thoroughly mixed and 0.9 ml of triethanolamine was added. The pH of the ; solution was measured and found to be pH 6.97.
Glycerol, in an amount of 250 ml was added. The urease enzyme from Jack Bean source, having an activity of 122 U/mg was added in an amount of 1.0 g which was dissolved in 10 ml of water prior to additions. The mixture was thoroughly mixed to dissolve the materials.

;'7~7~7 The resultan-t solu-tion provided an enzyme concentrate solution which was diluted in the ratio of one par-t enzyme con-centrate solution to nine parts water. The diluted solu-tion had a pH 7.03 and was useful in -the determination of urea in a sample when used in a Beckman BUN ~nalyzer 2 and "ASTRA" (T.M.).
The enzyme concentrate solution and the diluted solutions formed therefrom exhibited good stability.

The procedure of Example 1 was repeated in every essential la detail except the components were combined in the followiny amounts:
500 ml Distilled H20 4.14 g HEPES
1.0 g 2,4-Dichlorophenol 2.8 g Na2EDTA
1.88 ml Triethanolamine which provided a p~l 7.0 +0.05. ~o this solution was added 500 ml glycerol and 250 KU urease (salt free).
The resultant solution was a stabilized urease concentrate solution which was diluted in a 1:9 ratio with water to provide a diluted stabilized urease solution which had utility in the BUN
Analyzer 2 for determining urea in a sample.
In a first diluted solution (1:9 with water), the solution had a measured conductivity of 36 which corresponded to a 47 for a 2 mM NaC1 solution on the analyzer's linear scale. This diluted solution provides a standard solution which can be used in setting the scale of the BUN Analyzer 2.

it7~;74~
~ 14a -In a second diluted solution (1:9 with water), the solution had a measured conductivity of 38 when measured as above. This diluted solution also had utility as a standard solution in calibrating the BUN Analyzer 2.
The concentrate and diluted solutions exhibited extended shelf-lives.

~i7~7 12~23 15 1 E~ample_ ~ primary solution was prepared by mixing 0.45 liters of triethallol~mine in 0.91 li-ters of dis-tilled ~atex. To the mi.Yture was added 0.02922 ICg of ~DTA (frce acld) and dissolved. There was then added 0.04766 Kg of HRPES and 0.001 KcJ 2,4-dichlorophenol. The resu]tant primary solution was filtered through a glass fiber filter to remove any gross undissolved particles.
A st~bilized reagent concentr~te solution was pre-pared by mi~ing 0.1 liters of the above prepared primary solution and 0.505 liters of glycerol. Into the mixture was sprinkled 250 KIU urease which was allowed to dissolve into the mixture by diffusion at 2-8C. When the urease had dissolved, the resultant solution was gently mixed for about one hour to obtain a homogeneous solution.
The resulting stabilized reagent concentrate solution is diluted in a ratio of one part concentrate to 10 parts ~ater to obtain the working or useable stabilized urease enzyme solution fox use in the Beckman BUN Analyzer 2.

Example 4 The procedure of Example 3 was repeated in every essential detail except the formed stabilized reagent concentrate solution was diluted with a diluent which 2s ~as 0.004 percent by weight 2,4-dichlorophenol. The 0.004 percent diluent solution was prepared by adding 50 ml of 0.4 percent by weight aqueous 2,4-dichlorophenol solution to 1.765 liters of distilled water.
c diluent solution is then combined with 200 ml ~() of thc stabilizcd enzyme conccntrate solution to provide a cliluted stabilized urease enzyme so]ution which can be used ~or urea ana]ysis in the Beckman suN ~na]yzer 2 The resultant diluted stabilized urease solution was sta~le ~or one month at room tempera-ture.
.~ .

~ 16 The procedure of Example 1 was repeated in every essen-tial detail with the exception that the stabilized urease concentrate solution had the following composition:
HEPES 18mM ~ 5%
EDTA ~1 OmM
Urease 250,000 IU/l ~ 5%

The above concentrate solution was diluted by mixing 1 ml of the concentrate with 9 ml of deionized water. The diluted stabilized urease solution had the following compositions:

HEPES 1. 8 mM
EDTA ~ lmM
Urease 25,000 IU/l The diluted stabilized urease solution was a clear, clean 15 solution having a pH 7.10 ~ 0.2 at 25C. The solution had a linearity of 2 percent at 50 mg/dl and 5 percent at 100 mg/dl (lml diluted reagent + 10 microliter sample). The dynamic range ~or the diluted solution was 100 mg/dl. The concentrated stabilized urease solution had a stability of 72 hours at 41C. The diluted stabilized urease solution exhibited a stability of four weeks at room temperature and four months under regrigeration (~ 4-8C).

~7~7 1 ~xample 6 __.
~ stabilized urease solution was prepared by mixing 50.6 ml triple distilled water and 61 mg tris(hydro~ymethyl)aminomethane. To the mixture was added 70 mg HF.P~S with mi~ing. To this mixture ~as added 100 mg Na2EDTA. Anhydrous glyc~rol was added in an amount of 50.6 ml and the mixture mixed Eor about one hour.
The PH was adjusted by addiny HEPES to 7.60 ~ 0.02.
To the solution was added 75,000 IU/l urease which was added in the manner described in Example 3. The urease had an activity of 58,424 IU/g. The amount of urease was 128 mg. Diffusion took about two to three hours and the resultant solution was thoroughly mixed after dissolution with gentle stirring for about two to three hours.

Example 7 ~ The procedure of Example 6 was repeated in every ; 20 essential detail except the components were present in the following amounts:

Tripled Distilled H2O 200 ml Tris(hydroxymethyl)aminomethane 0.244 g ~5 HEPES 0.350 y EDTA 0 500 g Glycerol (anhydrous) 200 ml Vrease 0.640 g It has been found that the stabilized enzyme solutions herein hav~ and retain sufficient activity to provide good precision alld assay of urea when formulated by the method descril~ed herein.

.

Claims (21)

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. A stabilizing urease solution comprising water, an amount of a buffering agent which is at least one zwitterionic, low-conductivity buffering agent present to provide a pH in the range of from about 5 to about 9, a bacteriostat, a polyhydroxy organic compound, and urease.
2. A stabilized urease solution as recited in claim 1 wherein the buffering agent is N-2-hydroxymethyl-piperazine-N'-2-ethanesulfonic acid in an amount of about 0.5 to about 5 percent by weight of the water.
3. A stabilized urease solution as recited in claim 1 wherein the water is essentially heavy metalfree.
4. A stabilized urease solution as recited in claim 2 wherein the water is essentially heavy metalfree.
5. A stabilized urease solution as recited in any one of claims 1 to 3 wherein the bacteriostat is 2,4-dichlorophenol.
6. A stabilized urease solution as recited in any one of claims 1 to 3 wherein the bacteriostat is present in an amount from about 0.1 to about 1.0 percent by weight.
7. A stabilized urease solution as recited in any one of claims 1 to 3 wherein the bacteriostat is 2,4-dichlorophenol present in an amount from about 0.1 to about 1.0 percent by weight.
8. A stabilized urease solution as recited in any one of claims 1 to 3 wherein a chelating agent is present in an amount sufficient to chelate with any heavy metals present in the solution.
9. A stabilized urease solution as recited in any one of claims 1 to 3 wherein a chelating agent is present comprising ethylenediamine-tetraacetic acid in an amount sufficient to chelate with any heavy metals present in the solution.
10. A stabilized urease solution as recited in any one of claims 1 to 3 wherein the buffering agent is triethanolamine.
11. A stabilized urease solution as recited in any one of claims 1 to 3 wherein the polyhydroxy organic compound is selected from the group consisting of glycerol, ethylene glycol, sorbitol, and propylene glycol.
12. A stabilized urease solution as recited in any one of claims 1 to 3 wherein the polyhydroxy organic compound is present in an amount of about 50 percent by volume.
13 A stabilized urease solution as recited in any one or claims 1 to 3 wherein the polyhydroxy organic compound is selected from the group consisting of glycerol, ethylene glycol, sorbitol, and propylene glycol is present in an amount of about 50 percent by volume.
14. A stabilized urease solution as recited in any one of claims 1 to 3 wherein the urease is present in an amount greater than 25,000 IU/1.
15 . A stabilized urease solution as recited in any one of claims 1 to 3 wherein the urease is present in an amount of about 25,000 IU/1.
16. A stabilized urease solution as recited in claim 1 or 3 wherein the buffering agent is selected from the group consisting of triethanolamine, tris(hydroxymethyl)aminomethane, diethanolamine, aminomethyl propanol and mixtures thereof.
17. A stabilized urease solution comprising:
essentially heavy-metal-free water;
N-2-hydroxyethyl-piperazine-N'-2-ethanesulfonic acid in an amount from about 0.5 to about 5 percent by weight of the water;
a zwitterionic, low-conductivity buffering agent in an amount sufficient to provide a pH within the range of about 5 to 9 and selected from the group consisting of N-2-hydroxyethyl-piperazine-N'-2-ethanesulfonic acid, triethanolamine, tris(hydroxymethyl)aminomethane, diethanolamine, aminomethyl propanol and mixtures thereof;
a bacteriostat in an amount sufficient to prohibit bacterial growth, selected from 2,4-dichlorophenol and alcohols that are nondegradative to urease;
a chelating agent in an amount sufficient to chelate with any heavy metals present, selected from ethylenediaminetetraacetic acid and amino acids, a polyhydroxy organic compound in an amount of about 50 percent by volume of the solution and selected from the group consisting of glycerol, ethylene glycol, sorbitol and propylene glycol; and urease in an amount greater than about 25,000 IO/l ?
25%.
18. A kit comprising a stabilized concentrated urease solution comprising;
water, n-2-hydroxymethyl-piperazine-N'-2-ethanesulfonic acid, 2,4-dichlorophenol, ethylenediaminetetraacetic acid, trithanolamine and a polyhydroxy organic compound selected from the group consisting of glycerol, ethylene glycol, sorbitol and propylene glycol, and urease enzyme in an amount greater than 25,000 IU/l ? 25%.
19. A kit comprising a stabilized concentrated urease solution comprising essentially heavy-metal-free water;
N-2-hydroxyethly-piperazine-N'-2-ethanesulfonic acid in an amount from about 0.5 to about 5 percent by weight of the water, 2,4-dichlorophenol in an amount from about 0.1 to about 1.0 percent by weight, ethylene-diaminetetraacetic acid in an amount sufficient to chelate with any heavy metals present in the solution;
triethanolamine in an amount sufficient to provide a pH
within the range of about 5 to 9, and a polyhydroxy organic compound in an amount of about 50 percent by volume of the solution and selected from the group consisting of glycerol, ethylene glycol, sorbitol and propylene glycol; and urease enzyme in an amount greater than 25,000 IU/l ?
25%.
20. A kit as recited in claim 18 or 19 further comprising a diluent solution selected from water and a 0.004 percent by weight aqueous solution of 2,4-dichlorophenol for combining with the stabilized concentrated urease solution to form a stabilized diluted urease solution having a urease activity of about 25,000 IU/l + 25%.
21. A kit as recited in claim 18 or 19 further comprising a diluent solution selected from heavy-metal-free water and a 0.004 percent by weight essentially heavy-metal-free aqueous solution of 2,4-dichlorophenol for combining with the stabilized concentrated urease solution to form a stabilized diluted urease solution having a urease activity of about 25,000 IU/l ? 25%
CA000366092A 1980-12-03 1980-12-03 Stabilized enzymic solutions for determining urea Expired CA1167747A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000366092A CA1167747A (en) 1980-12-03 1980-12-03 Stabilized enzymic solutions for determining urea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000366092A CA1167747A (en) 1980-12-03 1980-12-03 Stabilized enzymic solutions for determining urea

Publications (1)

Publication Number Publication Date
CA1167747A true CA1167747A (en) 1984-05-22

Family

ID=4118631

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000366092A Expired CA1167747A (en) 1980-12-03 1980-12-03 Stabilized enzymic solutions for determining urea

Country Status (1)

Country Link
CA (1) CA1167747A (en)

Similar Documents

Publication Publication Date Title
US4282316A (en) Stabilized enzymic solutions for determining urea
US4378430A (en) Method of forming stabilized urease solutions
EP0034213B1 (en) A stabilized aqueous coenzyme solution for use in a clinical assay, a method of stabilizing a labile coenzyme in an aqueous clinical assay solution and a kit for use in said clinical assay
RU2054674C1 (en) Method of potassium ion concentration assay in biological material
Kusche et al. Comparison of the14C-putrescine assay with the NADH test for the determination of diamine oxidase: description of a standard procedure with a high precision and an improved accuracy
EP0253520B1 (en) Stabilized liquid enzyme composition for glucose determination
US4465770A (en) Stabilized enzymic solutions for determining urea
CN113092746B (en) Biochemical calibration material
JP2854995B2 (en) Uric acid measurement reagent composition
US5278044A (en) Stable aqueous NADH reagent and kit
CA1167747A (en) Stabilized enzymic solutions for determining urea
EP0570588A1 (en) Method and reagent for determination of serum iron or unsaturated iron binding capacity
Perakis et al. Kinetic approach for the enzymic determination of creatinine.
Bruce et al. Two-point determination of plasma ammonia with the centrifugal analyzer.
JPH01108997A (en) Method and reagent for particularly determining fructosamine content of serum in blood or specimen derived from blood,and method for removing specimen component causing nonspecific reductive action or/and suspension
EP0636885B1 (en) Method for determining the fructosamine content
JP4130724B2 (en) Reagent containing chelating substance
US3539453A (en) Reagent and method for assaying lactate dehydrogenase
JP3934498B2 (en) Quantitative method and reagent using protease-containing reagent
US3546074A (en) Reagent for assaying glutamate oxaloacetate transaminase
US7300769B2 (en) Stabilized coenzyme solutions for determining dehydrogenase activity
JP2001061498A (en) Reduced coenzyme solution
US5888828A (en) Kit for measuring urea nitrogen
Girotti et al. Bioluminescence flow system for determination of branched-chain L-amino acids in serum and urine
JPH0155880B2 (en)

Legal Events

Date Code Title Description
MKEX Expiry